| RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.78 |
Evidence |
|
| RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
0.78 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
0.78 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
0.78 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.78 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
0.78 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
0.78 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.78 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
DRD1 |
DRD1: D(1A) dopamine receptor |
0.78 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
RHO |
RHO, OPN2: Rhodopsin |
0.78 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.78 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.78 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
0.78 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.78 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
0.78 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
0.78 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
0.78 |
Evidence |
O
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.78 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
0.78 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.78 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
TSHR |
IPI00386365 |
0.78 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
0.78 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
0.78 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.78 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.78 |
Evidence |
|